Oncology (lung), three protein biomarkers, immunoassay using Q4 magnetic nanosensor technology, plasma, algorithm reported as risk score for likelihood of malignancy at Medical City Alliance

Compare to other hospitals

See Oncology (lung), three protein biomarkers, immunoassay using Q4 magnetic nanosensor technology, plasma, algorithm reported as risk score for likelihood of malignancy pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.